Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 4 June 2027
- Last conf. stmt
- 21 May 2026
Oxford Biosystems Limited
- Incorporated
- 14 February 2001 (25 years)
- Industry
- Wholesale of pharmaceutical goods (46460)
- Directors
- Fiona Elizabeth Alcock
- Owned by
- Accounts type
- Total exemption full
- Region
- South East
- Address
- 180 D/e Park DriveMilton ParkAbingdonOX14 4SE
Charges
- Total
- 4
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 4
Officers 1 active
Officer details are public data from the Companies House register.
Alcock, Fiona Elizabeth
Director · Appointed 1 January 2017
British
Born June 1966 (60)
Officer history (12 former)
4 November 2022
Resigned Kostka, Michal as Director
4 November 2022
Resigned Milata, Matej as Director
8 April 2022
Resigned Church, Helen Elizabeth as Secretary
1 September 2019
Resigned Ruzicka, Viktor, Dr as Director
21 May 2019
Resigned Upton, Mark, Mr. as Director
1 January 2017
Appointed Alcock, Fiona Elizabeth as Director
31 December 2016
Resigned Coombes, John as Director
16 January 2015
Appointed Ruzicka, Viktor, Dr as Director
16 January 2015
Appointed Kostka, Michal as Director
16 January 2015
Appointed Milata, Matej as Director
16 January 2015
Resigned Alcock, Fiona Elizabeth as Director
16 January 2015
Resigned Church, Helen Elizabeth as Director
3 April 2013
Resigned Coombes, Edward John as Director
25 July 2011
Appointed Alcock, Fiona Elizabeth as Director
28 January 2011
Appointed Upton, Mark, Mr. as Director
23 December 2005
1 June 2002
Appointed Coombes, Edward John as Director
4 March 2001
Appointed Church, Helen Elizabeth as Director
14 February 2001
14 February 2001
14 February 2001
14 February 2001
14 February 2001
14 February 2001
Appointed Coombes, John as Director
14 February 2001
Appointed Church, Helen Elizabeth as Secretary
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 14 October 2022
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited Company
Reg. no. 14327371
Former controllers (1)
14 October 2022
Ceased Biovendor Limited — Owns 75–100% of shares
Financials
Balance sheet as at 31 December 2025 · total exemption full accounts
- Net Assets
- £238,931
- Cash
- £73,643
- Employees
- 14
- Debt Ratio
- 59%
- Current Ratio
- 1.5x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Fixed Assets | £97,652 | £95,329 | £102,697 |
| Current Assets | £486,504 | £468,894 | £562,259 |
| Debtors | £286,214 | £318,739 | £405,194 |
| Cash | £73,643 | £22,778 | £62,905 |
| Creditors (< 1 year) | (£329,099) | (£421,812) | (£478,663) |
| Net Current Assets | £157,405 | £47,082 | £83,596 |
| Net Assets | £238,931 | £130,814 | £173,513 |
| Shareholder Funds | £238,931 | £130,814 | £173,513 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 2 June 2026 | Confirmation statement with updates | 21 May 2026 | ||
| 13 April 2026 | Total exemption full accounts | 31 December 2025 | ||
| 22 September 2025 | Total exemption full accounts | 31 December 2024 | ||
| 21 May 2025 | Confirmation statement with updates | 21 May 2025 | ||
| 28 August 2024 | Total exemption full accounts | 31 December 2023 |
Some other companies at this address
Other companies in this industry
Borehamwood
Stoke-On-Trent
Manchester
Newcastle
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →